Early Approval For Astra's Asthma Drug Stuns Analysts
By Marius Meland · July 22, 2006, 12:00 AM EDT
In a blow to GlaxoSmithKline Plc, rival AstraZeneca Plc has secured a surprisingly early U.S. Food and Drug Administration approval for Symbicort, an asthma drug that will compete directly with Glaxo's...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login